Gensia Sicor Announces Organizational Changes

Irvine, California (PROTEXT) - Gensia Sicor Inc. (Nasdaq:GNSA) today announced two management changes. Frank Becker, amember of Gensia Sicor's Board of Directors, has been appointedto the newly created position of Executive Vice President andChief Operating Officer and will be responsible for overallchemical, fermentation and pharmaceutical operations. Michael D.Cannon, currently Executive Vice President, USA and President,Gensia Sicor Pharmaceuticals, will move to the newly createdposition of Executive Vice President and Chief Scientific Officerand will focus on the research and development and regulatoryefforts throughout the company. Carlo Salvi, president and chief executive officer stated,"These organizational changes are aimed at providing strategicleadership to key functions of the company, as well as expeditingthe decision-making process and accelerating the integration ofour worldwide operations. With the addition of Frank Becker, weadd significant manufacturing and operational depth to ourcurrent management team and are now well positioned to fullyrealize Gensia Sicor's potential and to aggressively pursue theopportunities of the marketplace." Mr. Becker is the founder of Greenfield Chemical, Inc., whichprovides procurement and sourcing services to the pharmaceuticalindustry, as well as consulting services to chemicalmanufacturers to help improve manufacturing efficiencies,production planning, capital plans and strategic planning ofassets. Mr. Becker retired from Abbott Laboratories in 1997,where he was Vice President, Chemical Process Research andDevelopment. Mr. Becker holds a Bachelor of Science degree inChemical Engineering from Purdue University and a MBA from theUniversity of Chicago. Mr. Becker was awarded a DistinguishedEngineering Award in 1997 from Purdue and is the holder ofthirteen patents. Gensia Sicor Inc. is a vertically integrated pharmaceuticalcompany with proven expertise in the development, manufacturingand marketing of injectable pharmaceuticals and in the productionof active pharmaceutical ingredients utilizing synthesis orfermentation. The company is focused on the worldwide oncologyand injectable pharmaceutical markets. Gensia Sicor's commercialpharmaceutical businesses include Gensia Sicor Pharmaceuticals,Inc., a California-based manufacturer and marketer of multisourceinjectable drugs, SICOR-Societa Italiana Corticosteroidi S.p.A.and Diaspa S.p.A., both of Milan Italy, and Sicor de Mexico, S.A.de C.V. in Toluca, Mexico all which produce active pharmaceuticalingredients, and Lemery, S.A. de C.V. in Mexico City whichmanufactures injectable and oral finished multisource drugproducts. Gensia Sicor's company offices are located in Irvine,CA. This press release contains forward looking statements thatare subject to risks and uncertainties that could cause actualresults to differ materially from those set forth in the forwardlooking statements and those matters set forth in the riskfactors section of Gensia Sicor's filings on Forms 10-K and 10-Qwith the Securities and Exchange Commission. These forwardlooking statements represent the Company's judgment as of thedate of this press release. The Company disclaims any intent orobligation to update these forward looking statements. For more information on the Company, visit Gensia Sicor's newweb site at http://www.gensiasicor.com. News releases are alsoavailable at no charge through PR Newswire's News On-Call faxservice. For a menu of available news releases or to retrieve aspecific release made by Gensia Sicor, call 800-758-5804,extension 354050. Please retain these numbers for futurereference. ots Original Text Service: Gensia Sicor Inc.Internet: http://www.newsaktuell.de Contact: Laurie W. Littleof Gensia Sicor Inc., Tel.: (in the USA) 949-455-4879; orCarolyn Bass or Jim Byers, Tel.: (in the USA) 415-296-7383, orPatricia Walsh or Mark Owen, Tel.: (in the USA) 212-850-5600,all of Morgen-Walke Associates, Inc. Company News On-Call:http://www.prnewswire.com/comp/354050.html or fax, 800-758-5804,ext. 354050 Web site: http://www.gensiasicor.com

Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.

PROTEXT